Skip to main content

International Psoriasis Council

Advancing Knowledge. Improving Care.

Matthew

Vesely

,

MD, PhD

Assistant Professor
Yale University
New Haven
,
Connecticut
,
United States
2021 Fellow
IPC Jr. Councilor
Dr. Matthew Vesely is an Assistant Professor of Dermatology at Yale School of Medicine. He is a physician-scientist focusing on inflammatory skin diseases, including psoriasis, cutaneous lupus, and lichen planus. Dr. Vesely leads a basic and translational immunology research program investigating immune resolution pathways in the skin. His work focuses on the role of immune checkpoint receptors and vascular dysfunction in chronic inflammation. His group explores immune checkpoint agonism and endothelial normalization as potential therapeutic strategies in psoriasis and related conditions. Dr. Vesely earned his MD and PhD degrees from Washington University in St. Louis and completed his dermatology residency at Yale. He was named an IPC Fellow in 2021 under the mentorship of Dr. Alice Gottlieb. In 2025, he received a Discovery Grant from the National Psoriasis Foundation (NPF).
Last Updated:
07/06/2025

Areas of Interest

Development of Psoriatic Arthritis, Novel Drug Discovery

Languages Spoken

English

Involvement with Other Organization(s)

Membership Committee in Society for Investigative Dermatology; Treasurer for New England Dermatology Society

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026